Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer.

Cheng YW, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, Barral S, Idrees K, Khan SA, Zeng Z, Rosenberg S, Notterman DA, Ott J, Paty P, Barany F.

Clin Cancer Res. 2008 Oct 1;14(19):6005-13. doi: 10.1158/1078-0432.CCR-08-0216.

2.

Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.

Haruta M, Arai Y, Sugawara W, Watanabe N, Honda S, Ohshima J, Soejima H, Nakadate H, Okita H, Hata J, Fukuzawa M, Kaneko Y.

Genes Chromosomes Cancer. 2008 Aug;47(8):712-27. doi: 10.1002/gcc.20572.

PMID:
18464243
3.

Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.

Kaneda A, Wang CJ, Cheong R, Timp W, Onyango P, Wen B, Iacobuzio-Donahue CA, Ohlsson R, Andraos R, Pearson MA, Sharov AA, Longo DL, Ko MS, Levchenko A, Feinberg AP.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20926-31. Epub 2007 Dec 17.

4.

COPA--cancer outlier profile analysis.

MacDonald JW, Ghosh D.

Bioinformatics. 2006 Dec 1;22(23):2950-1. Epub 2006 Aug 7.

PMID:
16895932
5.

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer.

Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW.

Nat Genet. 2006 Jul;38(7):787-93. Epub 2006 Jun 25.

PMID:
16804544
6.

CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1.

Ling JQ, Li T, Hu JF, Vu TH, Chen HL, Qiu XW, Cherry AM, Hoffman AR.

Science. 2006 Apr 14;312(5771):269-72.

7.

Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.

Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, Nichols TD, Marks JR, Berchuck A.

Mol Cancer Res. 2006 Apr;4(4):283-92.

8.

The H19 gene: regulation and function of a non-coding RNA.

Gabory A, Ripoche MA, Yoshimizu T, Dandolo L.

Cytogenet Genome Res. 2006;113(1-4):188-93. Review.

PMID:
16575179
9.

Relationship of gene expression and chromosomal abnormalities in colorectal cancer.

Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E, Notterman DA.

Cancer Res. 2006 Feb 15;66(4):2129-37.

10.

Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.

Sasaki J, Konishi F, Kawamura YJ, Kai T, Takata O, Tsukamoto T.

Int J Cancer. 2006 Jul 1;119(1):80-3.

11.

Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.

Cheng YW, Shawber C, Notterman D, Paty P, Barany F.

Genome Res. 2006 Feb;16(2):282-9. Epub 2005 Dec 20.

12.

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM.

Science. 2005 Oct 28;310(5748):644-8.

13.

Active genes dynamically colocalize to shared sites of ongoing transcription.

Osborne CS, Chakalova L, Brown KE, Carter D, Horton A, Debrand E, Goyenechea B, Mitchell JA, Lopes S, Reik W, Fraser P.

Nat Genet. 2004 Oct;36(10):1065-71. Epub 2004 Sep 7.

14.
15.

Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.

Fottner Ch, Hoeflich A, Wolf E, Weber MM.

Horm Metab Res. 2004 Jun;36(6):397-405. Review.

PMID:
15241731
16.

Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women.

Woodson K, Flood A, Green L, Tangrea JA, Hanson J, Cash B, Schatzkin A, Schoenfeld P.

J Natl Cancer Inst. 2004 Mar 3;96(5):407-10.

PMID:
14996863
17.

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk.

Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP.

Science. 2003 Mar 14;299(5613):1753-5.

18.

Epigenetic modifications in an imprinting cluster are controlled by a hierarchy of DMRs suggesting long-range chromatin interactions.

Lopes S, Lewis A, Hajkova P, Dean W, Oswald J, Forné T, Murrell A, Constância M, Bartolomei M, Walter J, Reik W.

Hum Mol Genet. 2003 Feb 1;12(3):295-305.

PMID:
12554683
19.

Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.

Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP.

Cancer Res. 2002 Nov 15;62(22):6442-6.

20.

Chromosome translocations: dangerous liaisons revisited.

Rowley JD.

Nat Rev Cancer. 2001 Dec;1(3):245-50. doi: 10.1038/35106108. Review.

PMID:
11902580

Supplemental Content

Support Center